|Articles|March 1, 2004
Cohesive agent performs reliably in all stages of surgery
Cataract surgeons who choose sodium hyaluronate 1.2% (StaarVisc II, STAAR Surgical) for their routine cases know they can rely on it from beginning to end to offer all the features they seek in a viscoelastic.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
UPDATE: STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
2
Topcon Healthcare seeks to advance company through acquisition and new investment
3
VR and imaging advancements showcased at AAO 2025
4
Regeneron receives another CRL for its Eylea 8 mg
5













































.png)


